Breast Cancer Trial, Recruiting (NCT05512286)

Breast Cancer Trial, Recruiting NCT05512286 Sponsor: Fudan University Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05512286 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with invasive breast cancer confirmed by a tissue sample (biopsy).
People whose cancer is at a certain stage (classified as T0–3, T4b and N0–3a) and who need chemotherapy before surgery.
People who do not have cancer that has spread to other parts of the body.
People who are planned to receive radiation therapy after surgery and are considered suitable for a type of breast reconstruction called a DIEP flap at the time of their mastectomy.

Who may not be able to join:

People who are already taking part in another clinical trial that could affect the results of this study.
People who received chemotherapy before surgery but do not have an indication for radiation therapy.
People whose cancer continued to grow or spread during chemotherapy before surgery.
People who are pregnant or currently breastfeeding.
People who have a previous history of diabetes.
People who have a previous history of heavy smoking.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jiong Wu, Fudan University

Phone: 862164175590

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05512286

Sponsor: Fudan University

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 862164175590

More information: https://clinicaltrials.gov/study/NCT05512286

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with invasive breast cancer confirmed by a tissue sample (biopsy).
People whose cancer is at a certain stage (classified as T0–3, T4b and N0–3a) and who need chemotherapy before surgery.
People who do not have cancer that has spread to other parts of the body.
People who are planned to receive radiation therapy after surgery and are considered suitable for a type of breast reconstruction called a DIEP flap at the time of their mastectomy.

Who may not be able to join:

People who are already taking part in another clinical trial that could affect the results of this study.
People who received chemotherapy before surgery but do not have an indication for radiation therapy.
People whose cancer continued to grow or spread during chemotherapy before surgery.
People who are pregnant or currently breastfeeding.
People who have a previous history of diabetes.
People who have a previous history of heavy smoking.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fudan University

Registry

ClinicalTrials.gov

Start date

25 August 2022

Est. completion

1 July 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Patient satisfaction with breasts questionnaire Patient satisfaction of breast

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov